News | April 27, 2022
Lasa Supergenerics bags Rs. 50 crore orders
These bulk orders will contribute to the topline of the company as well as help in improving EBITDA of the company
These bulk orders will contribute to the topline of the company as well as help in improving EBITDA of the company
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
In addition, common light chain antibodies generated by RenLite mice can greatly improve the efficiency of downstream assembly of complex drug molecules such as bispecific antibodies and bispecific antibody-drug conjugates (bsADCs)
The respective expertise of Lonza and Integral Molecular will benefit drug developers in the assessment of the risk for off-target binding and activation
The new lab in the industrial town is SRL’s 4th lab in the state of Jharkhand
The approval comes soon after Corbevax was given the nod for 12-15-year group
Covaxin was earlier approved for children 12-18 years of age
The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19
Continuation of pediatric expansion in adolescents of PREVENT-19 Phase 3 trial will evaluate safety and immunogenicity of a booster dose
All the capex is being met through internal accruals only
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
